Eli Lilly's lower-priced insulin hits the market

Eli Lilly & Co.'s lower-priced authorized generic version of Humalog, an insulin injection, is now available for order in pharmacies, the drugmaker announced May 22.

The authorized generic, Insulin Lispro, will have a list price 50 percent lower than Humalog's current list price of about $275 per vial.

Insulin Lispro will sell for $137.35 for a single vial. A five-pack of the insulin pens will be $265.20.

Eli Lilly and other drug companies have come under increased pressure from lawmakers and the public to reduce the cost of prescription drugs in the U.S. Lawmakers have specifically targeted the skyrocketing price of insulin.

More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck's Keytruda fails late-stage trial as standalone treatment for breast cancer

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers